Cited by 254Cancer-related Molecular PathwaysLymphoma Diagnosis and TreatmentViral-associated cancers and disorders

The DOI matches its Crossref record; 55 of the 59 references it cites were found in a registry or an index.

p53 is frequently mutated in Burkitt's lymphoma cell lines

Open access

Farrell, P.J., Allan, G.J., Shanahan, F., Vousden, K.H., Crook, T.·1991·The EMBO Journal

DOI 10.1002/j.1460-2075.1991.tb07837.xPMC PMC452998

Open this paper in CoChat — free account Open PDF

Abstract

A panel of 12 Burkitt's lymphoma cell lines and four other B cell lines were tested for the presence of mutations in p53. Protein analysis using a mutant-specific antibody and sequencing of both cDNA and genomic DNA revealed changes relative to the standard p53 protein sequence in 12 of the 16 lines studied, including 10 of the BL lines. Mutation of p53 in the BL lines was usually accompanied by loss of the other allele of p53. Testing of the mutated p53 cDNAs for gain of transforming activity or loss of growth suppression activity showed that several of the BL mutants were functionally altered from wild-type p53.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/j.1460-2075.1991.tb07837.x

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 7,937
Purification of Biologically Active Globin Messenger RNA by Chromatography on Oligothymidylic acid-Cellulose
Aviv, H., & Leder, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1408 · Cited by 6,636
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K. R., Signer, S. H., Davidson, N. E., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,730
Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.
McMaster, G. K., & Carmichael, G. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4835 · Cited by 2,406
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.
Dalla‐Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,764

Show all 59 references

Research works printed but not linked: 13

Aviv,H. and Leder,P. (1972) Proc. Nat!. Acad. Sci. USA, 64, 1408-1412.
Dalla-Favera,R., Brejni,M., Erikson,J., Patterson,D., Gallo, R.C. and Croce,C.M. (1982) Proc. Natl. Acad. Sci. USA, 79, 7824-7827.
Eliyahu,D., Michalovitz,D., Eliyahu,S., Pinhasi-Kimhi,O. and Oren,M. (1989) Proc. Natl. Acad. Sci. USA, 86, 8763-8767.
Hinuma,Y. and Grace,J.T. (1967) Proc. Soc. Exp. Biol. Med., 124, 107-111.
Hollstein,M.C., Metcalf,R.A., Welsh,J.A., Montesano,R. and Harris,C.C. (1990) Proc. Natl. Acad. Sci. USA, 87, 9958-9961.
Lenoir,G.M., Vuillaume,M. and Bonnardel,C. (1985) IARC Publications No 60, pp. 309-318.
McMaster,G.K. and Carmichael,G.C. (1977) Proc. Natl. Acad. Sci. USA, 74, 4835-4838.
Miller,G., Shope,T., Lisco,H., Stitt,D. and Lipman,M. (1972) Proc. Natl. Acad. Sci. USA, 69, 383-387
Rodrigues,N.R., Rowan,A., Smith,M.E.G., Kerr,I.B., Bodmer,W.F., Gannon,J.F. and Lane,D.P. (1990) Proc. Natl. Acad. Sci. USA, 87, 7555 -7559.
Sanger,F., Nicklen,S. and Coulson,A.R. (1977) Proc. Natl. Acad. Sci. USA, 74, 5463-5467.
Thomas,P.S. (1980) Proc. Natl. Acad. Sci. USA, 77, 5201-5205.
van Santen,V., Cheung,A. and Kieff,E. (1981) Proc. Natl. Acad. Sci. USA, 78, 1930-1934
zur Hausen,H., Schulte-Holthausen,H., Klein,G., Henle,W., Henle,G., Clifford,P. and Santesson,L. (1970) Nature, 228, 1056-1058. Received on April 30, 1991; revised on June 5, 1991 Note added in proof Mutations of p53 in BL have also been reported recently by Gaidano et al. (1991) (Proc. Natl. Acad. Sci. USA, 88. 5413-5417).

Sorted by citations

Items 101–200 of 254

p53 expression in lymphatic malignancies.
Soini, Y., Pääkkö, P. K., Alavaikko, M. J., & Vähäkangas, K. (1992) · Journal of Clinical Pathology · doi:10.1136/jcp.45.11.1011 · Cited by 43
Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis
Bieging-Rolett, K. T., Amick, A. C., & Longnecker, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907994106 · Cited by 41
Disruption of Tacc3 function leads to in vivo tumor regression
Yao, R., Natsume, Y., Saiki, Y., Shioya, H., Takeuchi, K., Yamori, T., Toki, H., Aoki, I., Saga, T., & Noda, T. (2011) · Oncogene · doi:10.1038/onc.2011.235 · Cited by 40
Restoration of Wild‐Type p53 Function in Human Tumors: Strategies for Efficient Cancer Therapy
Wiman, K. G. (2007) · Advances in cancer research · doi:10.1016/s0065-230x(06)97014-6 · Cited by 40
Modulation of p53 activity by IκBα: Evidence suggesting a common phylogeny between NF-κB and p53 transcription factors
Dreyfus, D. H., Nagasawa, M., Gelfand, E. W., & Ghoda, L. Y. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-12 · Cited by 39
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma
Hüllein, J., Slabicki, M. M., Rosołowski, M., Jethwa, A., Habringer, S., Tomska, K., Kurilov, R., Lu, J., Scheinost, S., Wagener, R., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3438 · Cited by 38
The p53 tumor suppressor gene
Soussi, T. (1995) · Advances in genome biology · doi:10.1016/s1067-5701(06)80005-7 · Cited by 37
Epstein--Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assays
Inman, G. J., & Farrell, P. J. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-9-2141 · Cited by 37
Self-citation
Biomarkers in upper aerodigestive tract tumorigenesis: a review.
Shin, D. M., Hittelman, W. N., & Hong, W. K. (1994) · PubMed · Cited by 37
Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine
Höglund, A., Nilsson, L. M., Forshell, L. P., Maclean, K. H., & Nilsson, J. A. (2009) · Blood · doi:10.1182/blood-2008-10-183475 · Cited by 36
MYC, Metabolic Synthetic Lethality, and Cancer
Hsieh, A. L., & Dang, C. V. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_4 · Cited by 38
Frondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cells
Dyshlovoy, S. A., Rast, S., Hauschild, J., Otte, K., Alsdorf, W. H., Madanchi, R., Kalinin, V. I., Silchenko, A. S., Avilov, S. A., Dierlamm, J., et al. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1317091 · Cited by 35
Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma
Nakajima, K., Kawashima, I., Koshiishi, M., Kumagai, T., Suzuki, M., Suzuki, J., Mitsumori, T., & Kirito, K. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.09.023 · Cited by 35
Stable expression of Epstein-Barr virus BZLF-1–encoded ZEBRA protein activates p53-dependent transcription in human Jurkat T-lymphoblastoid cells
Dreyfus, D. H., Nagasawa, M., Kelleher, C. A., & Gelfand, E. W. (2000) · Blood · doi:10.1182/blood.v96.2.625 · Cited by 35
Biological Activities of p53 Mutants in Burkitt's Lymphoma Cells
Vousden, K. H., Farrell, P. J., & Crook, T. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-5-803 · Cited by 35
Self-citation
Overexpression of p53 in Hodgkin's disease: Lack of correlation with Epstein–Barr virus infection
Niedobitek, G., Rowlands, D. C., Young, L. S., Herbst, H., Williams, A., Hall, P. D., Padfield, J., Rooney, N., & Jones, E. L. (1993) · The Journal of Pathology · doi:10.1002/path.1711690206 · Cited by 35
Function and Conformation of Wild-Type p53 Protein Are Influenced by Mutations in Bovine Leukemia Virus-Induced B-Cell Lymphosarcoma
Tajima, S., Zhuang, W. Z., Kato, M. V., Okada, K., Ikawa, Y., & Aida, Y. (1998) · Virology · doi:10.1006/viro.1998.9051 · Cited by 34
Inactivation of Myc-induced p53-dependent apoptosis in human tumors
Arsenian‐Henriksson, M., Selivanova, G., Lindström, M. S., & Wiman, K. G. (2001) · APOPTOSIS · doi:10.1023/a:1009644716727 · Cited by 32
Molecular genetic analysis of Epstein-Barr virus Cp promoter function
Evans, T. J., Farrell, P. J., & Swaminathan, S. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1695-1705.1996 · Cited by 33
Self-citation
Functional interaction of wild-type and mutant p53 transfected into human tumor cell lines carrying activated ras genes.
Sharma, S., Schwarte‐Waldhoff, I., Oberhuber, H., & Schäfer, R. (1993) · PubMed · Cited by 33
KSHV vCyclin counters the senescence/G1 arrest response triggered by NF-κB hyperactivation
Zhi, H., Zahoor, M. A., Shudofsky, A. D., & Giam, C. (2014) · Oncogene · doi:10.1038/onc.2013.567 · Cited by 32
GCN5 HAT inhibition reduces human Burkitt lymphoma cell survival through reduction of MYC target gene expression and impeding BCR signaling pathways
Farria, A. T., Mustachio, L. M., Coban‐Akdemir, Z., & Dent, S. (2019) · Oncotarget · doi:10.18632/oncotarget.27226 · Cited by 32
Transforming Growth Factor-β Directly Induces p53-up-regulated Modulator of Apoptosis (PUMA) during the Rapid Induction of Apoptosis in Myc-driven B-cell Lymphomas
Spender, L. C., Carter, M. J., O’Brien, D. I., Clark, L., Yu, J., Michalak, E. M., Happo, L., Cragg, M. S., & Inman, G. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410274 · Cited by 33
Enhancement of genetic instability in human B cells by Epstein-Barr virus latent infection
Gualandi, G. (2001) · Mutagenesis · doi:10.1093/mutage/16.3.203 · Cited by 32
Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells
Menendez, D., Lowe, J. M., Snipe, J., & Resnick, M. A. (2016) · Oncotarget · doi:10.18632/oncotarget.11210 · Cited by 31
Coordinated repression of BIM and PUMA by Epstein–Barr virus latent genes maintains the survival of Burkitt lymphoma cells
Fitzsimmons, L., Boyce, A. J., Wei, W., Chang, C. W. T., Croom-Carter, D. S. G., Tierney, R. J., Herold, M. J., Bell, A. I., Strasser, A., Kelly, G. L., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.150 · Cited by 31
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53
Tirrò, E., Massimino, M., Romano, C., Pennisi, M. S., Stella, S., Vitale, S. R., Fidilio, A., Manzella, L., Parrinello, N. L., Stagno, F., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00057 · Cited by 32
Reactivation of Epstein-Barr Virus by HIF-1α Requires p53
Kraus, R. J., Cordes, B.-L. A., Sathiamoorthi, S., Patel, P., Yuan, X., Iempridee, T., Yu, X., Lee, D. L., Lambert, P. F., & Mertz, J. E. (2020) · Journal of Virology · doi:10.1128/jvi.00722-20 · Cited by 32
A Novel Raji-Burkitt's Lymphoma Model for Preclinical and Mechanistic Evaluation of CD52-Targeted Immunotherapeutic Agents
Lapalombella, R., Zhao, X. B., Triantafillou, G., Yu, B., Jin, Y., Lozanski, G., Cheney, C. M., Heerema, N. A., Jarjoura, D. G., Lehman, A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1006 · Cited by 28
Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma
Tomska, K., Kurilov, R., Lee, K.-S., Hüllein, J., Lukas, M., Sellner, L., Walther, T., Wagner, L., Oleś, M., Brors, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30509-3 · Cited by 28
Transactivators Zta and Rta of Epstein–Barr virus promote G0/G1 to S transition in Raji cells: A novel relationship between lytic virus and cell cycle
Guo, Q., Lü, Q., Guo, L., Shi, M., Chen, C., Lv, X., Yu, M., Hu, M., Jiang, G., & Guo, N. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.02.017 · Cited by 28
In Vivo Effects of the Epstein–Barr Virus Small RNA EBER-1 on Protein Synthesis and Cell Growth Regulation
Laing, K. G., Elia, A., Jeffrey, I. W., Matys, V., Tilleray, V. J., Souberbielle, B. E., & Clemens, M. J. (2002) · Virology · doi:10.1006/viro.2002.1354 · Cited by 28
The impact of R213 mutation on p53-mediated p21 activity
Zhang, Y., Zhang, Y., Zhao, H., Zhai, Q., Zhang, Y., & Shen, Y. (2014) · Biochimie · doi:10.1016/j.biochi.2013.12.017 · Cited by 27
Latent Epstein-Barr Virus Can Inhibit Apoptosis in B Cells by Blocking the Induction of NOXA Expression
Yee, J., White, R. E., Anderton, E., & Allday, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028506 · Cited by 27
Deregulation of the Cell Cycle by the Epstein–Barr Virus
O’Nions, J., & Allday, M. J. (2004) · Advances in cancer research · doi:10.1016/s0065-230x(04)92006-4 · Cited by 28
TP 53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM 4 expression as the only TP 53 pathway abnormality detected in a subset of cases
Leventaki, V., Rodic, V., Tripp, S. R., Bayerl, M. G., Perkins, S. L., Barnette, P., Schiffman, J. D., & Miles, R. R. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09243.x · Cited by 26
Targeting p53 for immune modulation: Exploring its functions in tumor immunity and inflammation
Wu, H. H., Leng, S., Eisenstat, D. D., Sergi, C. M., & Leng, R. P. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217614 · Cited by 27
Identification of stathmin 1 expression induced by Epstein–Barr virus in human B lymphocytes
Baik, S. Y., Yun, H. S., Lee, H. J., Lee, M. H., Jung, S.-Y., Kim, J. W., Jeon, J. P., Shin, Y.-J., Rhee, H. S., Kimm, K., et al. (2007) · Cell Proliferation · doi:10.1111/j.1365-2184.2007.00429.x · Cited by 26
Effects of adenoviral wild-type p53 gene transfer in p53 -mutated lymphoma cells
Buttgereit, P., Schakowski, F., Märten, A., Brand, K., Renoth, S., Ziske, C. G., Schöttker, B., Ebert, O., Schroers, R., & Schmidt‐Wolf, I. G. H. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700323 · Cited by 26
Decreased or Altered Expression of the FHIT Gene in Human Leukemias
Sugimoto, K., Yamada, K., Miyagawa, K., Hirai, H., & Oshimi, K. (1997) · Stem Cells · doi:10.1002/stem.150223 · Cited by 26
Alterations of p53 and c-myc in the clonal evolution of malignant lymphoma
Chang, H., Benchimol, S., Minden, M., & Messner, H. (1994) · Blood · doi:10.1182/blood.v83.2.452.452 · Cited by 26
Detection of mutations in the p53 gene in human head and neck carinomas by single strand conformation polymorphism analysis
Chang, Y., Lin, Y.-J., Tsai, C., Shu, C., Tsai, M.-S., Choo, K., & Liu, S.-T. (1992) · Cancer Letters · doi:10.1016/0304-3835(92)90140-q · Cited by 26
Iron deprivation induces apoptosis independently of p53 in human and murine tumour cells
Truksa, J., Kovár̆, J., Valenta, T., Ehrlichová, M., Polak, J., & Naumann, P. W. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00280.x · Cited by 25
Promoter Hypermethylation of the DNA-Repair Gene O 6 -Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
Hiraga, J., Kinoshita, T., Ohno, T., Mori, N., Ohashi, H., Fukami, S., Noda, A., Ichikawa, A., & Naoe, T. (2006) · International Journal of Hematology · doi:10.1532/ijh97.06087 · Cited by 24
Rac1 targeting suppresses p53 deficiency–mediated lymphomagenesis
Bosco, E. E., Ni, W., Wang, L., Guo, F., Johnson, J. F., & Zheng, Y. (2010) · Blood · doi:10.1182/blood-2009-02-202440 · Cited by 24
Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells
Kleeff, J. H., Kornmann, M., Sawhney, H., & Korc, M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000501)86:3 · Cited by 146
Reciprocal antagonism of steroid hormones and BZLF1 in switch between Epstein-Barr virus latent and productive cycle gene expression
Sinclair, A. J., Brimmell, M., & Farrell, P. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.70-77.1992 · Cited by 24
Self-citation
Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines
Karpova, M. B., Schoumans, J., Blennow, E., Ernberg, I., Henter, J., Смирнов, А. Ф., Nordenskjöld, M., & Fadeel, B. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.3.605 · Cited by 24
p53‐induced inhibition of protein synthesis is independent of apoptosis
Constantinou, C., Bushell, M., Jeffrey, I. W., Tilleray, V. J., West, M., Frost, V. J., Hensold, J. O., & Clemens, M. J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03687.x · Cited by 25
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Interacts with Multifunctional Angiogenin To Utilize Its Antiapoptotic Functions
Paudel, N., Sadagopan, S., Chakraborty, S., Sarek, G., Ojala, P. M., & Chandran, B. (2012) · Journal of Virology · doi:10.1128/jvi.00070-12 · Cited by 23
Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides
Métay, C., Mir, L. M., Carlier, K., Lécluse, Y., Tétaud, C., Mishal, Z., & Wiels, J. (2001) · Blood · doi:10.1182/blood.v97.4.1043 · Cited by 23
A molecular study of EBV DNA and p53 mutations in nasopharyngeal carcinoma of Saudi Arab patients
Nasrin, N., Taiba, K., Hannan, N., Hannan, M. A., & Al‐Sedairy, S. T. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90011-6 · Cited by 23
Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
Poole, C. J., Zheng, W., Lee, H., Young, D., Lodh, A., Chadli, A., & van Riggelen, J. (2018) · Cancers · doi:10.3390/cancers10110448 · Cited by 22
Involvement of 5-lipoxygenase in survival of Epstein–Barr virus (EBV)-converted B lymphoma cells
Belfiore, M. C., Natoni, A., Barzellotti, R., Merendino, N., Pessina, G., Ghibelli, L., & Gualandi, G. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.03.010 · Cited by 22
p53 Expression in Non-Hodgkin's Lymphomas: A Marker of p53 Inactivation?
Piris, M. A., Villuendas, R., Martinez, J. C., Sánchez‐Beato, M., Orradre, J. L., Mateo, M. S., & Martinez, P. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509051701 · Cited by 22
A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal
van den Bosch, C. (2012) · Advances in Hematology · doi:10.1155/2012/494758 · Cited by 21
()-Epigallocatechin-3-Gallate Inhibits EBV Lytic Replication via Targeting LMP1-Mediated MAPK Signal Axes
Li, H., Li, Y., Hu, J., Liu, S., Luo, X., Tang, M., Bode, A. M., Dong, Z., Liu, X., Liao, W., et al. (2021) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504021x16135618512563 · Cited by 21
Developments in Burkitt's lymphoma: novel cooperations in oncogenic MYC signaling
Inman, G. J., & Spender, L. C. (2014) · Cancer Management and Research · doi:10.2147/cmar.s37745 · Cited by 28
APC2 and Axin promote mitotic fidelity by facilitating centrosome separation and cytoskeletal regulation
Poulton, J. S., Mu, F. W., Roberts, D. M., & Peifer, M. A. (2013) · Development · doi:10.1242/dev.094425 · Cited by 19
Monoallelic p53 deletion in chronic lymphocytic leukemia detected by interphase cytogenetics
Amiel, A., Arbov, L., Manor, Y., Fejgin, M. D., Elis, A., Gaber, E., & Lishner, M. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00341-x · Cited by 19
Effect of Cell Cycle Stage, Dose Rate and Repair of Sublethal Damage on Radiation-Induced Apoptosis in F9 Teratocarcinoma Cells
Langley, R. E., Quartuccio, S., Kennealey, P. T., Coleman, C. N., & Bump, E. A. (1995) · Radiation Research · doi:10.2307/3579240 · Cited by 19
The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status
Turinetto, V., Porcedda, P., Orlando, L., Marchi, M., Amoroso, A., & Giachino, C. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-281 · Cited by 17
Analysis of p53 status in human cell lines using a functional assay in yeast: Detection of new non-sense p53 mutation in codon 124
Šmardová, J., Pavlová, Š., Svitáková, M., Grochová, D., & Ravčuková, B. (2005) · Oncology Reports · doi:10.3892/or.14.4.901 · Cited by 18
Epstein-Barr virus infection and mitogen stimulation of normal B cells induces wild-type p53 without subsequent growth arrest or apoptosis.
Tamm, K. P., Okan, İ., Kashuba, E., L√∂wbeer, M., Klein, G., & Székely, L. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-4-987 · Cited by 18
Levels of p53 in Epstein–Barr Virus-Infected Cells Determine Cell Fate: Apoptosis, Cell Cycle Arrest at the G1/S Boundary without Apoptosis, Cell Cycle Arrest at the G2/M Boundary without Apoptosis, or Unrestricted Proliferation
Chen, W., Huang, S., & Cooper, N. R. (1998) · Virology · doi:10.1006/viro.1998.9431 · Cited by 18
Dok1 expression and mutation in Burkitt's lymphoma cell lines
Lee, S., Huang, H., Niu, Y., Tommasino, M., Lenoir, G., & Sylla, B. S. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.10.045 · Cited by 17
ZNF 385 B is characteristically expressed in germinal center B cells and involved in B ‐cell apoptosis
Iijima, K., Yamada, H., Miharu, M., Imadome, K., Miyagawa, Y., Akimoto, S., Kobayashi, K., Okita, H., Nakazawa, A., Fujiwara, S., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201242530 · Cited by 17
Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1
Wang, Q., Lingel, A., Geiser, V., Kwapnoski, Z., & Zhang, L. (2017) · Journal of Virology · doi:10.1128/jvi.00312-17 · Cited by 17
Mnt modulates Myc-driven lymphomagenesis
Campbell, K. J., Vandenberg, C. J., Anstee, N. S., Hurlin, P. J., & Cory, S. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.131 · Cited by 16
Multistep evolution of B-cell-derived tumors in humans and rodents
Klein, G. (1993) · Gene · doi:10.1016/0378-1119(93)90065-b · Cited by 16
State of mutational alterations of p53 and retinoblastoma susceptibility genes in papillomavirus‐negative small cell cervical carcinomas
Pao, C. C., Kao, S., Chen, J. H., Tang, G., Chang, P. Y., & Tan, T. T. (1994) · Journal of Surgical Oncology · doi:10.1002/jso.2930570204 · Cited by 16
Expression of p53, bcl-2 and growth hormone receptor in actinic keratosis, hypertrophic type
Stanimirović, A., Čupić, H., Bošnjak, B., Krušlin, B., & Belicza, M. (2003) · Archives of Dermatological Research · doi:10.1007/s00403-003-0400-0 · Cited by 15
17p Anomalies in Lymphoid Malignancies: Diagnostic and Prognostic Implications
Schoch, C., Rieder, H., Stollmann-Gibbels, B., Freund, M., Tischler, H., Silling-Engelhardt, G., & Fonatsch, C. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509056832 · Cited by 15
Genome‐wide search for loss of heterozygosity in Burkitt lymphoma cell lines
Sobol, H., Benziane, A., Kerangueven, F., Yin, L., Noguchi, T., Pauly, S., Eisinger, F., Longy, M., Romeo, G., Lenoir, G., et al. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10022 · Cited by 15
Paediatric orofacial tumours: New oral health concern in paediatric patients
Omoregie, F., & Akpata, O. (2014) · Ghana Medical Journal · doi:10.4314/gmj.v48i1.2 · Cited by 14
The Ubiquitin Sensor and Adaptor Protein p62 Mediates Signal Transduction of a Viral Oncogenic Pathway
Wang, L., Howell, M. E. A., Sparks-Wallace, A., Zhao, J., Hensley, C. R., Nicksic, C. A., Horne, S. R., Mohr, K. B., Moorman, J. P., Yao, Z. Q., et al. (2021) · mBio · doi:10.1128/mbio.01097-21 · Cited by 15
Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma
Chumduri, C., Gillissen, B. F., Richter, A. M., Richter, A., Milojkovic, A., Overkamp, T., Müller, A., Pott, C., & Daniel, P. T. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1242-2 · Cited by 14
Smac-mediated sensitization of human B-lymphoma cells to staurosporine- and lactacystin-triggered apoptosis is apoptosome-dependent
Sun, Y., Ottosson, A., Pervaiz, S., & Fadeel, B. (2007) · Leukemia · doi:10.1038/sj.leu.2404660 · Cited by 12
A p53 Axis Regulates B Cell Receptor-Triggered, Innate Immune System-Driven B Cell Clonal Expansion
Lee, H., Haque, S., Nieto, J., Trott, J., Inman, J. K., McCormick, S. A., Chiorazzi, N., & Mongini, P. K. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103037 · Cited by 13
Estimating the prevalence of cancer in the United States
Polednak, A. P. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970701)80:1 · Cited by 30
Construction, Expression, and Purification of p28 as a Cell-Penetrating Peptide with Anticancer Effects on Burkitt’s Lymphoma Cell Line
Abuei, H., Behzad‐Behbahani, A., Dehbidi, G. R., Pirouzfar, M., Zare, F., & Farhadi, A. (2019) · Shiraz E-Medical Journal · doi:10.5812/semj.85190 · Cited by 11
Chemo-sensitizing effects of EP4 receptor-induced inactivation of nuclear factor-κB
Gobec, M., Prijatelj, M., Delić, J., Markovič, T., & Mlinarič‐Raščan, I. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.08.039 · Cited by 11
Gene Therapy of Lymphoma
Buttgereit, P., & Schmidt‐Wolf, I. G. H. (2002) · Stem Cells and Development · doi:10.1089/15258160260090924 · Cited by 11
Accumulation of p53 in infectious mononucleosis tissues
Ehsan, A., Fan, H., Eagan, P. A., Siddiqui, H. A., & Gulley, M. L. (2000) · Human Pathology · doi:10.1016/s0046-8177(00)80010-6 · Cited by 11
p53 gene analysis in childhood B non - Hodgkin's lymphoma
Klumb, C. E., de Resende, L. M. M., Tajara, E. H., Pavarino, É. C., Rumjanek, V. M., & Maia, R. C. (2001) · Sao Paulo Medical Journal · doi:10.1590/s1516-31802001000600006 · Cited by 11
Occurrence of point mutations in p53 gene is not increased in patients with acute myeloid leukaemia carrying an activating N‐ras mutation
Büheer‐Leclerc, M., Gratwohl, A. A., & Senn, H. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb03099.x · Cited by 11
Human B lymphocytes and non-Hodgkin's lymphoma cells become polyploid in response to the protein kinase inhibitor SU6656
Dussault, N., Simard, C., Néron, S., & Côté, S. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.02.010 · Cited by 9
Non-conservative homologous recombination in human B lymphocytes is promoted by activation-induced cytidine deaminase and transcription
Mierau, M., Drexler, G. A., Kutzera, A., Braunschmidt, K., Ellwart, J. W., Eckardt‐Schupp, F., Fritz, E., Bachl, J., & Jungnickel, B. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn542 · Cited by 9
The impact of p53 loss on murine plasmacytoma development
Mai, S., & Wiener, F. (2002) · Chromosome Research · doi:10.1023/a:1015200307448 · Cited by 9
An in vitro model to study chemoresistance in non-Hodgkin's lymphoma patients over-expressing mutant p53
Foroutan, B., Ruf, A. A., Costall, B., & Anderson, D. C. (2006) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2006.05.008 · Cited by 9
Accumulation of p53 protein correlates with tumour proliferative activity in EBV positive Burkitt's lymphoma
Lehtinen, T., Isola, J. J., Aine, R., Alavaikko, M. J., & Lehtinen, M. (1992) · Hematological Oncology · doi:10.1002/hon.2900100505 · Cited by 9
Expression of p53 Protein in Prostate Cancers of Different Histologic Types
Losi, L., Gregório, C., Brausi, M. A., Fante, R., & HURLIMANN, J. (1994) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80411-5 · Cited by 9
SV40 and p53 as team players in childhood lymphoproliferative disorders
Heinsohn (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.967 · Cited by 7
Lack of CD54 Expression and Mutation of p53 Gene Relate to the Prognosis of Childhood Burkitt's Lymphoma
Kaneko, H., Sugita, K., Kiyokawa, N., Iizuka, K., Takada, K., Saito, M., Yoshimoto, K., Itakura, M., Kokai, Y., & Fujimoto, J. (1996) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199609093443 · Cited by 8
p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long term cell lines but may be acquired in acute myeloid leukemia cells in vitro
Sen, S., Zhou, H., Andersson, B. S., Cork, A., Freireich, E. J., & Stass, S. A. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(94)00282-g · Cited by 8
Loss of functional pRB is not a ubiquitous feature of B-cell malignancies
Sinclair, A. J., & Frost, V. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690408 · Cited by 8
Suppression of ras oncogene-mediated transformation
Schäfer, R. (2006) · Springer eBooks · doi:10.1007/bfb0031031 · Cited by 8
Epstein-Barr virus latent membrane protein 1 subverts IMPDH pathways to drive B-cell oncometabolism
Burton, E. M., Maestri, D., White, S., Liang, J., Mitra, B., Asara, J. M., & Gewurz, B. E. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013092 · Cited by 8
miR‐129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63‐dependent manner
Zou, H., Zou, R., Chen, K., Zhu, C., Tian, X., You, Y., & He, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27189 · Cited by 7
Single Cell Detection of the p53 Protein by Mass Cytometry
Fagerholt, O. H. E., Hellesøy, M., Gullaksen, S., & Gjertsen, B. T. (2020) · Cancers · doi:10.3390/cancers12123699 · Cited by 7

Authors: Farrell, P. J., Allan, G. J., Shanahan, F., Vousden, K. H., & Crook, T.
Affiliations: St Mary's Hospital (GB)
ORCID: Farrell, P.J.
Shanahan, F.
Vousden, K.H.
Crook, T.
Venue: The EMBO Journal
Publisher: Springer Science and Business Media LLC
Published: 1991-10-01
Volume: 10
Issue: 10
Pages: 2879-2887
ISSN: 0261-4189 (ISSN-L)
1460-2075
DOI: 10.1002/j.1460-2075.1991.tb07837.x
PMC: PMC452998
OpenAlex: W196344020
Cited by: 254
References: 59
Citations by year: 2025: 3 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 6 · 2018: 6 · 2017: 6 · 2016: 3 · 2015: 3 · 2014: 12 · 2013: 1 · 2012: 14
FWCI: 9.46
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: The EMBO Journal (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Keywords: p53, Burkitt lymphoma, TP53 mutation, B-cell lymphoma cell lines, loss of heterozygosity, tumor suppressor
MeSH terms: Alleles, Amino Acid Sequence, Animals, Base Sequence, Burkitt Lymphoma, DNA, DNA, Neoplasm, Humans, Molecular Sequence Data, Mutation, Precipitin Tests, RNA, Neoplasm, Tumor Cells, Cultured, Blotting, Southern, Blotting, Northern, Blotting, Western, Polymerase Chain Reaction, Tumor Suppressor Protein p53

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

p53 is frequently mutated in Burkitt's lymphoma cell lines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks